Skip to content

Statin and PAF in Patients With Pacemaker

Atorvastatin Decreases Atrial Fibrillation Burden in Patients With Paroxysmal Atrial Fibrillation

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00201552
Enrollment
Unknown
Registered
2005-09-20
Start date
Unknown
Completion date
Unknown
Last updated
2005-09-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Paroxysmal Atrial Fibrillation

Brief summary

Statin could decrease AF burden

Detailed description

Statin could decrease AF burden in patients with PAF.

Interventions

DRUGStatin

Sponsors

National Taiwan University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 90 Years

Inclusion criteria

* Patients with pacemaker

Exclusion criteria

* Patients with hepatic dysfunction

Countries

Taiwan

Contacts

Primary ContactChia-Ti Tsai, MD
fang31@ms39.hinet.net886-2-23123456

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026